Adipose Tissue in Obesity—An Inflammatory Issue
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
White adipose tissue (WAT), long regarded as a “Cinderella organ,” has truly emerged into the limelight, and much of the stimulus for this relates to the current concern with obesity. This disease now affects over one in five adults in the United Kingdom, for example, with even more in the United States, and is associated with a reduced life expectancy and an increased incidence of several major diseases, particularly type II diabetes, coronary heart disease, and cancer. An important recent development is the emergence of the concept that obesity, like diabetes, is characterized by chronic low-grade inflammation (1, 2). WAT is itself recognized as an important site of the production of inflammation-related proteins, the production of which is (generally) increased in the obese (3, 4). Considerable interest was aroused just over a year ago by two reports that demonstrated that, in obesity, adipose tissue is infiltrated by macrophages (5, 6). One important factor produced by adipocytes underlying this infiltration is monocyte chemoattractant protein-1 (MCP-1) (7, 8); another may be macrophage migration inhibitory factor (MIF), and a key paper by Skurk et al. (9), in this issue of Endocrinology, demonstrates that MIF is secreted from human adipocytes and that the rate of secretion (in culture) is positively correlated with the body mass index of the subjects. MIF, which was originally identified in activated T lymphocytes as a cytokine that inhibited the migration of macrophages from capillaries, is part of the accelerating list of protein factors and signals secreted from white adipocytes—the adipokines (3, 4, 10). The recognition that protein signals are secreted from adipocytes began in effect with adipsin in the late 1980s (11) and was followed by the proinflammatory cytokine TFNα a few years later (12). The pivotal event in our evolving perspective on WAT as a secretory organ was the discovery in 1994 of leptin (13); this resulted in the characterization of the tissue as a critical endocrine system. Currently, more than 50 different adipokines are recognized, and these are highly heterogeneous both in terms of protein structure and of function (3, 4, 10). The adipokines are implicated in a wide range of physiological processes, including appetite and energy balance, glucose homeostasis, lipid metabolism, blood pressure regulation, hemostasis, and angiogenesis (3, 4, 10). An increasing number of adipokines are directly linked to inflammation and the inflammatory response (Fig. 1), and these encompass classical cytokines (e.g. TNFα, IL-1β, IL-6, IL-10) and acute-phase proteins (e.g. haptoglobin, plasminogen activator inhibitor-1, serum amyloid A), as well as other inflammation-related signals such as MCP-1, nerve growth factor, and adiponectin (3, 4). Adiponectin, a major adipocyte-derived hormone with a role in insulin sensitivity, has a distinct antiinflammatory action (14). Inflammation-related adipokines and signals for macrophage infiltration into WAT. Only factors for which secretion from adipocytes has been clearly demonstrated are shown. NGF, Nerve growth factor; PAI-1, plasminogen activator inhibitor-1; VEGF, vascular endothelial growth factor. The expression and secretion of MIF by adipose tissue was first described in mice and was found to be strongly up-regulated in 3T3-L1 adipocytes by TNFα (15). Whether TNFα also stimulates the synthesis and release of MIF in human adipocytes is not yet known, but, interestingly, Skurk et al. (9) indicate that neither lipopolysaccharide, IFN-γ, nor IL-4 have any effect on MIF secretion in human fat cells differentiated in culture. Stimulation of MIF in human adipocytes by TNFα would be expected not only because of the data from the murine cell line (15), but also because this cytokine has pleiotropic effects on the production of inflammation-related adipokines in humans, including the stimulation of IL-6, MCP-1, and nerve growth factor expression (16). The capacity of human adipocytes to secrete MIF appears to be substantial, with similar levels of secretion from cells from the sc and omental depots (within the same individual). Some depot differences are evident, however; much lower rates of release are apparent with mammary fat cells (9). Although, with human adipocytes, high concentrations of insulin do not affect the expression and release of MIF (9), in 3T3-L1 cells, a role for insulin in regulating the production of the factor is suggested (17). Recent studies on human subjects have indicated that MIF mRNA levels are increased in circulating mononuclear cells in obesity and the plasma levels of the protein are also increased (18, 19). Indeed, this up-regulation of MIF is related to body mass index, with the plasma levels being suppressed by treatment with metformin (19). Thus, MIF is one of the growing number of inflammation-related proteins whose circulating levels are increased in obesity. These proteins include IL-6, C-reactive protein, TNFα and its s
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Self-citationInflammatory pathways and insulin action
Hotamisligil, G. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802502 · Cited by 717
Alessi, M. C., Bastelica, D., Morange, P., Berthet, B., Leduc, I., Verdier, M., Geel, O., & Juhan-Vague, I. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1374 · Cited by 344
Adipose tissue, insulin action and vascular disease: inflammatory signals
Yudkin, J. S. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802496 · Cited by 311
Weight loss reduces interleukin-18 levels in obese women
Esposito, K., Pontillo, A., Ciotola, M., Di Palo, C., Grella, E., Nicoletti, G., & Giugliano, D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8781 · Cited by 254
Cited by
Endocrine and signalling role of adipose tissue: new perspectives on fat
Trayhurn, P. (2005) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2005.01468.x · Cited by 502
Self-citationTlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat
Davis, J. E., Gabler, N. K., Walker‐Daniels, J., & Spurlock, M. E. (2008) · Obesity · doi:10.1038/oby.2008.210 · Cited by 334
Bradley, R. L., Jeon, J. Y., Liu, F.-F., & Maratos-Flier, E. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00309.2007 · Cited by 320
Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C., Zernicke, R. F., & Hart, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00112 · Cited by 308
Sex differences in the regulation of body weight
Shi, H., & Clegg, D. J. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.02.017 · Cited by 259
Metadata
- Authors
- Trayhurn, P.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-03-01
- Volume
- 146
- Issue
- 3
- Pages
- 1003-1005
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2087055868
- Cited by
- 118
- References
- 7
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adipose Tissue in Obesity—An Inflammatory Issue. https://app.cochat.ai/papers/10.1210/en.2004-1597
- The paper
- Trayhurn, P. (2005). Adipose Tissue in Obesity—An Inflammatory Issue. Endocrinology. https://doi.org/10.1210/en.2004-1597
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.